SLB N.V. (SLB) Stock Price & Analysis
SLB N.V. (SLB) closed at USD 49.55 on Thursday, October 22, 2026, down 3.03% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 51.1; the Oct 22, 2026 session ranged USD 48.7–51.16 on volume of 14,993,995 shares. Market capitalization is $73.54B, with a 52-week range of USD 34.65–60.46 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:28 UTC.
Also available as compact Markdown for AI agents: nexqual.com/SLB.md
Key facts (SLB)
- Last four reported quarters (through Jun 30, 2026): revenue $36.4B, net income $3.10B (8.5% margin), free cash flow $4.81B (SEC filings).
- Valuation: P/E 23.7x (avg 15.5x at the last 3 fiscal year-ends), net debt $7.07B.
- 7 of 80 tracked superinvestors hold SLB (13F, Q2 2026): 0 new, 1 added, 4 reduced, 2 unchanged.
- Insider open-market sales, last ~7 months: 8 Form 4 filings, $9.9M; 2 not under a Rule 10b5-1 plan ($3.1M); 1 by opportunistic insiders (1 outside 10b5-1 plans), 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 2.00 on a 1–5 scale) (30 analysts), mean target USD 62.28 (range 43–75).
- Total return with dividends: 1Y +41.0% vs S&P 500 +14.9%; 5Y +63.2% vs S&P 500 +80.3%.
- Next earnings: 2026-10-23, EPS estimate USD 0.61, revenue estimate $9.27B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (SLB)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $22.9B | $28.1B | $33.1B | $36.3B | $35.7B | $36.4B |
| Operating income | $3.37B | $5.01B | $6.52B | — | — | — |
| Net income | $1.88B | $3.44B | $4.20B | $4.46B | $3.37B | $3.10B |
| EPS (diluted) | $1.32 | $2.39 | $2.91 | $3.11 | $2.35 | — |
| Free cash flow | $3.51B | $2.10B | $4.70B | $4.67B | $4.79B | $4.81B |
| Operating margin | 14.7% | 17.8% | 19.7% | — | — | — |
| Net margin | 8.2% | 12.2% | 12.7% | 12.3% | 9.4% | 8.5% |
| Revenue growth | -2.8% | +22.5% | +18.0% | +9.5% | -1.6% | — |
| Cash + short-term investments | $3.14B | $2.89B | $3.99B | $4.67B | $4.21B | — |
| Total debt | $13.3B | $10.6B | $10.8B | $11.0B | $9.74B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (SLB)
P/E 23.7x · P/S 2.0x · EV/Sales 2.2x · P/FCF 15.3x · P/B 2.8x · FCF yield 6.54% · Earnings yield 4.22% · Dividend yield (paid, TTM) 2.30% · Net debt $7.07B · EV $80.6B
P/E at fiscal year-ends: Dec 2025 16.3x, Dec 2024 12.3x, Dec 2023 17.9x.
Superinvestors (SEC 13F-HR, Q2 2026) (SLB)
7 of 80 tracked investors hold SLB. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | 2.24% | $1.34B | Added +1.9% |
| Greenhaven Associates | 2.04% | $177M | Reduced -18.5% | |
| Van Den Berg Management I | 1.65% | $7.8M | Reduced -3.1% | |
| John Rogers | Ariel Investments | 0.54% | $54.1M | Reduced -6.0% |
| Torray Funds | 0.04% | $264K | Unchanged | |
| Dodge & Cox Funds | Dodge & Cox | <0.01% | $4.6M | Reduced -10.4% |
| Mairs & Power | Mairs & Power Funds | <0.01% | $256K | Unchanged |
Insider sales (SEC Form 4, open-market, last ~7 months) (SLB)
6 of 8 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Le Peuch Olivier | Chief Executive Officer | 35,000 | $2.1M | 2.6% | Yes (adopted May 27, 2026) | Too little history (no open-market trades in 2023–2025) |
| 2026-08-31 | Le Peuch Olivier | Chief Executive Officer | 5,000 | $300K | 0.4% | Yes (adopted May 27, 2026) | Too little history (no open-market trades in 2023–2025) |
| 2026-08-27 | Le Peuch Olivier | Chief Executive Officer | 5,000 | $275K | 0.4% | Yes (adopted May 27, 2026) | Too little history (no open-market trades in 2023–2025) |
| 2026-08-26 | Le Peuch Olivier | Chief Executive Officer | 25,000 | $1.3M | 1.8% | Yes (adopted May 27, 2026) | Too little history (no open-market trades in 2023–2025) |
| 2026-05-27 | Le Peuch Olivier | Chief Executive Officer | 25,000 | $1.4M | 1.8% | Yes (adopted March 25, 2025) | Too little history (no open-market trades in 2023–2025) |
| 2026-05-07 | De La Chevardiere Patrick | Director | 2,000 | $109K | 10.6% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-05-01 | Gassen Steve Matthew | EVP, Geographies | 53,379 | $3.0M | 50.1% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-04-29 | Le Peuch Olivier | Chief Executive Officer | 25,000 | $1.4M | 1.8% | Yes (adopted March 25, 2025) | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (SLB)
Consensus Buy (mean 2.00 on a 1–5 scale), 30 analysts; mean target USD 62.28 (low 43, high 75).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-19 | Citigroup | Target lowered | Buy | $63 → $62 |
| 2026-10-19 | Piper Sandler | Target lowered | Overweight | $64 → $63 |
| 2026-10-15 | Barclays | Target lowered | Overweight | $67 → $66 |
| 2026-09-14 | UBS | Target raised | Buy | $72 → $75 |
| 2026-09-09 | UBS | Target raised | Buy | $66 → $72 |
| 2026-07-27 | Piper Sandler | Target raised | Overweight | $59 → $64 |
| 2026-07-27 | TD Cowen | Target raised | Buy | $62 → $64 |
| 2026-07-27 | Morgan Stanley | Target raised | Overweight | $54 → $55 |
| 2026-07-27 | Evercore ISI Group | Target raised | Outperform | $63 → $66 |
| 2026-07-27 | Susquehanna | Target raised | Positive | $55 → $62 |
| 2026-07-27 | BMO Capital | Target raised | Outperform | $59 → $63 |
| 2026-07-27 | Barclays | Target raised | Overweight | $64 → $67 |
Total return (dividends reinvested) (SLB)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +41.0% | +63.2% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +41.1% | +10.3% |
| Volatility (annualized) | 36.2% | 40.3% |
| Max drawdown | -22.3% (Jun 2026→Jul 2026) | -44.8% (Sep 2023→Oct 2025) |
SLB analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.61 | $0.64 | -4.5% | $9.27B | 24 |
| Next quarter (ends Dec 2026) | $0.76 | $0.82 | -7.9% | $9.92B | 23 |
| Current fiscal year (ends Dec 2026) | $2.47 | $2.42 | +2.1% | $36.90B | 25 |
| Next fiscal year (ends Dec 2027) | $3.15 | $3.29 | -4.2% | $39.52B | 23 |
Key Statistics (as of October 23, 2026 at 09:28 UTC)
| Price | USD 49.55 |
|---|---|
| Change | ▼ 3.03% (down) |
| Previous Close | USD 51.1 |
| Open | USD 51 |
| Day Range | USD 48.7 – 51.16 |
| 52-Week Range | USD 34.65 – 60.46 |
| Volume | 14,993,995 shares |
| Market Cap | $73.54B |
| Exchange | NYQ |
Technical Analysis (SLB)
Nexqual's technical model rates SLB "SELL" based on 1 bullish and 4 bearish signals across 127 daily candles, as of October 23, 2026 at 09:28 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 41.14 (neutral) |
| vs SMA50 | Below (USD 52.45) |
| MACD | -0.68 (negative) |
Analyst Ratings (SLB)
Wall Street analysts rate SLB "Buy" based on 30 analysts, with a mean price target of USD 62.28 (range USD 43–75), per Nexqual as of October 23, 2026 at 09:28 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 30 |
| Mean Target | USD 62.28 |
| High Target | USD 75 |
| Low Target | USD 43 |
| Buy / Hold / Sell | 26 / 2 / 2 |
Earnings (SLB)
| Next Earnings Date | 2026-10-23 |
|---|---|
| EPS Estimate | USD 0.61 |
| Revenue Estimate | $9.27B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.55 vs est 0.52 ▲ beat |
| 2026-03-31 | USD 0.52 vs est 0.51 ▲ beat |
| 2025-12-31 | USD 0.78 vs est 0.74 ▲ beat |
| 2025-09-30 | USD 0.69 vs est 0.66 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:28 UTC.
Financials & Fundamentals (SLB)
| Total Revenue | $36.37B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +5.00% |
| Gross Margin | +16.99% |
| Operating Margin | +12.71% |
| Profit Margin | +8.53% |
| ROE | +12.91% |
| Debt / Equity | 0.47 |
| Current Ratio | 1.44 |
| Total Cash | $4.12B |
| Total Debt | $12.81B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $4.81B (13.2% of revenue) |
Source: Nexqual, October 23, 2026 at 09:28 UTC.
Financial Health Score (SLB)
Nexqual rates SLB N.V.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:28 UTC.
| Growth | Weak — Revenue -2% YoY (annual), declining |
|---|---|
| Profitability | Mixed — Gross margin 17%, operating 13% (last 12 months) |
| Balance Sheet | Solid — $4.07B cash and investments vs $11.1B debt (Jun 2026, SEC) |
| Cash Flow | Solid — FCF $4.81B (last 4 quarters to Jun 2026, SEC), 13% margin |
| Efficiency | Mixed — ROE 13%, ROA 6.2% |
Ownership (SLB)
| Insider Ownership | +0.22% |
|---|---|
| Institutional Ownership | +92.51% |
| Shares Outstanding | 1.48B |
| Float | 1.48B |
| Short % of Float | +4.65% |
Source: Nexqual, October 23, 2026 at 09:28 UTC.
Leadership (SLB)
SLB N.V. is led by Olivier Le Peuch, CEO & Director, per Nexqual as of October 23, 2026 at 09:28 UTC.
| CEO & Director | Olivier Le Peuch |
|---|---|
| Executive VP & CFO | Stephane Biguet |
| Chief Technology Officer | Demosthenis Pafitis |
| Executive Vice President of Core Services & Equipment | Abdellah Merad |
| Senior Vice President of Investor Relations & Industry Affairs | James R. McDonald |
Major Backers & Investors (SLB)
Notable institutional backers of SLB N.V. include Price (T.Rowe) Associates Inc, Charles Schwab Investment Management, Inc., Capital Group, according to Nexqual as of October 23, 2026 at 09:28 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Price (T.Rowe) Associates Inc | 4.15% |
| Charles Schwab Investment Management, Inc. | 3.25% |
| Capital Group | 3.2% |
| Morgan Stanley | 2.54% |
| Charles Schwab | 2.41% |
| UBS Group AG | 2.12% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 11.64% |
| BlackRock | 7.83% |
| State Street | 6.15% |
| Geode Capital | 2.38% |
Source: Nexqual, October 23, 2026 at 09:28 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BKR | Baker Hughes Company | USD 53.62 | ▼ 4.25% |
| TS | Tenaris S.A. | USD 56.37 | ▼ 3.92% |
| HAL | Halliburton Company | USD 33.19 | ▼ 2.35% |
| FTI | TechnipFMC plc | USD 66.82 | ▼ 4.54% |
| SEI | Solaris Energy Infrastructure, | USD 58.61 | ▼ 15.51% |
| NOV | NOV Inc. | USD 18.76 | ▼ 2.65% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:28 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt